# Yasuhiko Tomino

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yasuhiko-tomino/

## Facts

| Field | Value |
| --- | --- |
| Citations | 33,979 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 72 |
| i10-index | 402 |
| Last Known Institution | Showa Corporation |
| OpenAlex ID | https://openalex.org/A5078494019 |
| ORCID iD | https://orcid.org/0000-0003-2689-3620 |
| Works | 935 |

## Researcher papers

- [Revised Equations for Estimated GFR From Serum Creatinine in Japan](https://scholariq.org/papers/revised-equations-for-estimated-gfr-from-serum-creatinine-in-japan/)
- [The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-rationale-clinicopathological/)
- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [IgA nephropathy](https://scholariq.org/papers/iga-nephropathy-2/)
- [Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity](https://scholariq.org/papers/aberrantly-glycosylated-iga1-in-iga-nephropathy-patients-is-recognized-by-igg/)
- [Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial](https://scholariq.org/papers/febuxostat-therapy-for-patients-with-stage-3-ckd-and-asymptomatic-hyperuricemia/)
- [The MEST score provides earlier risk prediction in lgA nephropathy](https://scholariq.org/papers/the-mest-score-provides-earlier-risk-prediction-in-lga-nephropathy/)
- [IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1](https://scholariq.org/papers/iga1-secreting-cell-lines-from-patients-with-iga-nephropathy-produce-aberrantly/)
- [Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy](https://scholariq.org/papers/autoantibodies-targeting-galactose-deficient-iga1-associate-with-progression-of/)
- [The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults](https://scholariq.org/papers/the-oxford-iga-nephropathy-clinicopathological-classification-is-valid-for/)
- [Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan](https://scholariq.org/papers/prognosis-and-risk-factors-for-idiopathic-membranous-nephropathy-with-nephrotic/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [Showa Corporation](https://scholariq.org/institutions/showa-corporation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.